• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    DaVita HealthCare Partner (NY: DVA )

    141.59 +1.78 (+1.27%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,064,260
    Open 141.64
    Bid (Size) 141.03 (1)
    Ask (Size) 144.00 (2)
    Prev. Close 139.81
    Today's Range 140.50 - 143.42
    52wk Range 78.05 - 168.50
    Shares Outstanding 82,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why DaVita Stock Withered on Wednesday
    The company's profitability is going in the wrong direction for many investors. 
    Via The Motley Fool
    Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
    This week marks a firehose of earnings from several top Buffett holdings. 
    Via Investor's Business Daily

    Performance

    YTD
    +32.46%
    +32.46%
    1 Month
    -10.99%
    -10.99%
    3 Month
    +4.56%
    +4.56%
    6 Month
    +3.45%
    +3.45%
    1 Year
    +78.21%
    +78.21%

    More News

    Read More
    DaVita (DVA) Q3 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    What Analysts Are Saying About DaVita Stock
    Via Benzinga
    3 Buy Rated Stocks Cruising At 52 Week Highs
    Via Talk Markets
    Key Takeaways From DaVita Analyst Ratings
    Via Benzinga
    6 Analysts Assess DaVita: What You Need To Know
    Via Benzinga
    AdaptHealth Stock Earns RS Rating Upgrade
    Via Investor's Business Daily
    3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
    Via Talk Markets
    Bull Of The Day: Davita - Friday, September 6
    Via Talk Markets
    Top Medical Stocks To Hedge Against The September Effect
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    DaVita (DVA) Q2 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
    Via Benzinga
    2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
    Via The Motley Fool
    Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
    Via InvestorPlace
    These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
    Via The Motley Fool
    Topics Stocks
    Exposures US Equities
    Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
    Via Benzinga
    Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
    Via Investor's Business Daily
    The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
    Via InvestorPlace
    DaVita (DVA) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.